Literature DB >> 27929803

An autopsy-verified case of FTLD-TDP type A with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease.

Yuichi Hayashi1, Yasushi Iwasaki2, Akira Takekoshi1, Nobuaki Yoshikura1, Takahiko Asano3, Maya Mimuro2, Akio Kimura1, Katsuya Satoh4, Tetsuyuki Kitamoto5, Mari Yoshida2, Takashi Inuzuka1.   

Abstract

Here we report an autopsy-verified case of frontotemporal lobar degeneration (FTLD)-transactivation responsive region (TAR) DNA binding protein (TDP) type A with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease (sCJD). A 69-year-old woman presented with an 11-month history of progressive dementia, irritability, insomnia, and gait disturbance without a family history of dementia or prion disease. Neurological examination revealed severe dementia, frontal signs, and exaggerated bilateral tendon reflexes. Periodic sharp-wave complexes were not observed on the electroencephalogram. Brain diffusion MRI did not reveal abnormal changes. An easy Z score (eZIS) analysis for 99mTc-ECD-single photon emission computed tomography (99mTc-ECD-SPECT) revealed a bilateral decrease in thalamic regional cerebral blood flow (rCBF). PRNP gene analysis demonstrated methionine homozygosity at codon 129 without mutation. Cerebrospinal fluid (CSF) analysis showed normal levels of both 14-3-3 and total tau proteins. Conversely, prion protein was slowly amplified in the CSF by a real-time quaking-induced conversion assay. Her symptoms deteriorated to a state of akinetic mutism, and she died of sudden cardiac arrest, one year after symptom onset.  Despite the SPECT results supporting a clinical diagnosis of MM2-thalamic-type sCJD, a postmortem assessment revealed that this was a case of FTLD-TDP type A, and excluded prion disease. Thus, this case indicates that whereas a bilateral decreasing thalamic rCBF detected by 99mTc-ECD-SPECT can be useful for diagnosing MM2-thalamic-type sCJD, it is not sufficiently specific. Postmortem diagnosis remains the gold standard for the diagnosis of this condition.

Entities:  

Keywords:  MM2-thalamic-type sporadic Creutzfeldt-Jakob disease single photon emission computed tomography; TDP43; cerebral blood flow; frontotemporal dementia; motor neuron disease; thalamus

Mesh:

Substances:

Year:  2016        PMID: 27929803      PMCID: PMC5161298          DOI: 10.1080/19336896.2016.1243192

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  20 in total

1.  Frontotemporal dementia with severe thalamic involvement: a clinical and neuropathological study.

Authors:  Márcia Radanovic; Sérgio Rosemberg; Rogério Adas; Stênio C Miranda; Paulo Caramelli; Leonardo Caixeta; Ricardo Nitrini
Journal:  Arq Neuropsiquiatr       Date:  2004-01-06       Impact factor: 1.420

2.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

3.  Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease.

Authors:  Yasushi Iwasaki; Yoshio Hashizume; Mari Yoshida; Tetsuyuki Kitamoto; Gen Sobue
Journal:  Acta Neuropathol       Date:  2005-06-03       Impact factor: 17.088

4.  Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.

Authors:  M Riemenschneider; S Wagenpfeil; H Vanderstichele; M Otto; J Wiltfang; H Kretzschmar; E Vanmechelen; H Förstl; A Kurz
Journal:  Mol Psychiatry       Date:  2003-03       Impact factor: 15.992

5.  Thalamic syndrome and cortical hypoperfusion on technetium-99m HM-PAO brain SPECT.

Authors:  M S Lee; I S Choi; T S Chung
Journal:  Yonsei Med J       Date:  1989       Impact factor: 2.759

6.  Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT.

Authors:  Seiju Kobayashi; Masaru Tateno; Kumiko Utsumi; Akira Takahashi; Masaki Saitoh; Hidetoshi Morii; Kazuki Fujii; Masatoshi Teraoka
Journal:  J Neurol Sci       Date:  2007-08-30       Impact factor: 3.181

7.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; R W Shin; K Doh-ura; N Tomokane; M Miyazono; T Muramoto; J Tateishi
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

8.  Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.

Authors:  Masaaki Waragai; Tatsuo Yamada; Hiroshi Matsuda
Journal:  J Neurol Sci       Date:  2007-05-09       Impact factor: 3.181

9.  Vascular dementia with left thalamic infarction: neuropsychological and behavioral implications suggested by involvement of the thalamic nucleus and the remote effect on cerebral cortex. The Osaki-Tajiri project.

Authors:  Kenichi Meguro; Kyoko Akanuma; Yoshitaka Ouchi; Mitsue Meguro; Kei Nakamura; Satoshi Yamaguchi
Journal:  Psychiatry Res       Date:  2013-05-18       Impact factor: 3.222

Review 10.  Sporadic and familial CJD: classification and characterisation.

Authors:  Pierluigi Gambetti; Qingzhong Kong; Wenquan Zou; Piero Parchi; Shu G Chen
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

View more
  5 in total

1.  Pathological examination is required for the case of rapidly progressive dementia with only positive result of RT-QUIC assay.

Authors:  Yuichi Hayashi
Journal:  Prion       Date:  2017-12-14       Impact factor: 3.931

2.  An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Nobuaki Yoshikura; Takahiko Asano; Maya Mimuro; Akio Kimura; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takashi Inuzuka
Journal:  Prion       Date:  2017-07-27       Impact factor: 3.931

3.  Clinical findings of a probable case of MM2-cortical-type sporadic Creutzfeldt-Jakob disease with antibodies to anti-N-terminus of α-enolase.

Authors:  Yuichi Hayashi; Megumi Yamada; Akio Kimura; Takahiko Asano; Katsuya Satoh; Tetsuyuki Kitamoto; Makoto Yoneda; Takashi Inuzuka
Journal:  Prion       Date:  2017-10-30       Impact factor: 3.931

4.  Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease.

Authors:  Neil Watson; Peter Hermann; Anna Ladogana; Angeline Denouel; Simone Baiardi; Elisa Colaizzo; Giorgio Giaccone; Markus Glatzel; Alison J E Green; Stéphane Haïk; Daniele Imperiale; Janet MacKenzie; Fabio Moda; Colin Smith; David Summers; Dorina Tiple; Luana Vaianella; Gianluigi Zanusso; Maurizio Pocchiari; Inga Zerr; Piero Parchi; Jean-Philippe Brandel; Suvankar Pal
Journal:  JAMA Netw Open       Date:  2022-01-04

5.  A patient with spastic paralysis finally diagnosed as V180I genetic Creutzfeldt-Jakob disease 9 years after onset.

Authors:  Taichi Nomura; Ikuko Iwata; Ryoji Naganuma; Masaaki Matsushima; Katsuya Satoh; Tetsuyuki Kitamoto; Ichiro Yabe
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.